|

ADT Clinical Trials

7 actively recruiting trials across 5 locations

Also known as: Androgen Deprivation Therapy, Androgen deprivation therpay, Hormone Therapy

Other2 trials

National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Phase 1/2
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Phase 2

Anchorage, Alaska1 trial

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Anchorage Associates in Radiation Medicine

Phase 3

Antioch, California1 trial

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Kaiser Permanente-Deer Valley Medical Center

Phase 3

Duarte, California1 trial

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

City of Hope Medical Center

Phase 2

Bethesda, Maryland1 trial

M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer

National Institutes of Health Clinical Center

Phase 1/2

Houston, Texas1 trial

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.